#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pituitary-dependent Cushing's syndrome Skin angiosarcoma Anti-myelin-associated glycoprotein associated polyneuropathy Philadelphia chromosome positive Cystic fibrosis gastrointestinal disease Mantle cell lymphoma stage IV Rhabdomyosarcoma Alveolar rhabdomyosarcoma Progressive familial intrahepatic cholestasis Ichthyosis X-linked lymphoproliferative syndrome Pelizaeus-Merzbacher disease Malignant glioma Lung adenocarcinoma Haemolytic uraemic syndrome More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia recurrent – Treatment Wolfram syndrome – Trials in Disease Mantle cell lymphoma – Basic Information Atypical teratoid/rhabdoid tumour of CNS – Treatment Gastrointestinal stromal tumour Hypereosinophilic syndrome – Life with Disease Hepatoblastoma – Trials in Disease Pemphigoid – Trials in Disease Hairy cell leukaemia – Diagnostics Glycogen storage disease type V – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Evg321 Efruxifermin Ly3556050 Alitretinoin Metamizole Sodium Monohydrate Calcitriol Utreglutide Interferon Beta-1B ANOC-001 Ro7589655 Alpelisib Elraglusib Cefazolin Basiliximab Bilastine Olmesartan Medoxomil HUPERZINE A Tianeptine Sodium Ertapenem Simeticone More therapies…

    Learn about Your Condition

    Colour blindness Multiple sclerosis relapse Adrenal insufficiency Aortic valve disease Hyperinsulinism Renal cell carcinoma Dystonic tremor Pharyngeal cancer stage III Interstitial lung disease Post cardiac arrest syndrome Stem cell transplant Glaucoma Arterial tortuosity syndrome Ovarian cancer recurrent Systemic candida More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Microsatellite instability cancer

  • Study on PET Imaging with Fianlimab and Cemiplimab for Patients with Advanced Solid Tumors, with or without Platinum-Based Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Microsatellite instability cancer
    • Cervix carcinoma
    Investigated Drugs:
    • Fianlimab
    • Cemiplimab
    The Netherlands

  • Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Microsatellite instability cancer
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    France

  • Study of Monalizumab and Volrustomig for Patients with MSI and/or dMMR Metastatic Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Microsatellite instability cancer
    Investigated Drugs:
    • Monalizumab
    • Volrustomig
    France

  • Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Colorectal cancer stage IV
    • Microsatellite instability cancer
    Investigated Drugs:
    • Vibostolimab
    • Favezelimab
    • Mk-4830
    Belgium Denmark Estonia France Germany Greece +7

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!